pharma news today glp-1 obesity drug Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine Lilly is now pharma's top

Rosiglitazone monotherapy in mild-to-moderate Alzheimers disease: results from a randomized, double-blind, placebo-controlled phase III study

Footnotes Financial disclosure The authors are employees of Lane Clark and Peacock LLP, which advises life sciences organizations developing treatments for obesity

Levodopa offers significant benefits in motor function, independence, quality of life, and lifespan

Are these reasonable price wise

William Blair may or may not own any securities of the issuers referenced and, if such securities are owned, no representation is being made that such securities will continue to be held